PepGen Quote - PEPG

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.37

Bid

1.37

Ask

1.53

Volume

0.00 Day's Range 0.00

1.16 52 Week Range 19.298

Market Cap

44.656M

Previous Close

1.37

Open

Last Trade

1.65

Last Trade Time

04:21:37

Financial Volume

VWAP

Average Volume (3m)

337,923

Shares Outstanding

32,595,737

Dividend Yield

PE Ratio

-0.57

Earnings Per Share (EPS)

-2.41

Revenue

Net Profit

-78.63M

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

pepgen.com

Headquarters

Wilmington, Delaware, USA

Founded

PepGen Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PEPG. The last closing price for PepGen was US$1.37. Over the last year, PepGen shares have traded in a share price range of US$ 1.16 to US$ 19.298.

PepGen currently has 32,595,737 shares outstanding. The market capitalization of PepGen is US$44.66 million. PepGen has a price to earnings ratio (PE ratio) of -0.57.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

– Significant mean splicing correction of 29.1% following a single dose of PGN-EDODM1 at 10 mg/kg – – PGN-EDODM1 observed to have favorable...

Form 8-K - Current report

PepGen Announces CONNECT Program Updates

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of...

Form 8-K - Current report

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy

-Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- PepGen Inc. (Nasdaq: PEPG), a...

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.03	2.23880597015	1.34	1.81	1.24	320975	1.42640803	CS
4	-0.53	-27.8947368421	1.9	2.03	1.16	492943	1.35125113	CS
12	-3.63	-72.6	5	6.85	1.16	337923	2.60393304	CS
26	-8.32	-85.8617131063	9.69	10.14	1.16	206473	3.88906783	CS
52	-12.51	-90.1296829971	13.88	19.298	1.16	159735	7.28980701	CS
156	-14.23	-91.2179487179	15.6	20	1.16	124263	9.25187578	CS
260	-14.23	-91.2179487179	15.6	20	1.16	124263	9.25187578	CS

PEPG - Frequently Asked Questions (FAQ)

What is the current PepGen share price?

The current share price of PepGen is US$ 1.37

How many PepGen shares are in issue?

PepGen has 32,595,737 shares in issue

What is the market cap of PepGen?

The market capitalisation of PepGen is USD 44.66M

What is the 1 year trading range for PepGen share price?

PepGen has traded in the range of US$ 1.16 to US$ 19.298 during the past year

What is the PE ratio of PepGen?

The price to earnings ratio of PepGen is -0.57

What is the reporting currency for PepGen?

PepGen reports financial results in USD

What is the latest annual profit for PepGen?

The latest annual profit of PepGen is USD -78.63M

What is the registered address of PepGen?

The registered address for PepGen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the PepGen website address?

The website address for PepGen is pepgen.com

Which industry sector does PepGen operate in?

PepGen operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRMVroom Inc	US$ 24.50 (390.00%)	102
STECSantech Holdings Limited	US$ 2.79 (329.03%)	42.97M
RETOReTo Eco Solutions Inc	US$ 1.22 (200.57%)	20.13M
LINKInterlink Electronics Inc	US$ 13.00 (84.40%)	67
ORISOriental Rise Holdings Ltd	US$ 2.06 (83.93%)	15.19M
PHVSPharvaris NV	US$ 10.01 (-39.30%)	13
EBMTEagle Bancorp Montana Inc	US$ 12.01 (-33.35%)	22
HBNCHorizon Bancorp Inc	US$ 12.30 (-26.65%)	10
WDCWestern Digital Corporation	US$ 52.93 (-22.96%)	6.07k
JUNEJunee Ltd	US$ 3.20 (-22.52%)	3
STECSantech Holdings Limited	US$ 2.79 (329.03%)	42.97M
CNEYCN Energy Group Inc	US$ 0.3673 (50.16%)	35.78M
RETOReTo Eco Solutions Inc	US$ 1.22 (200.57%)	20.13M
ORISOriental Rise Holdings Ltd	US$ 2.06 (83.93%)	15.19M
ADTXAditxt Inc	US$ 0.0827 (-9.62%)	12.19M